Horn v. NuView Life Sciences, Inc. et al
Ian M Horn and Ian M. Horn |
Maury Dewald, NuView Molecular Pharmaceuticals, Inc., NuView Life Sciences, Inc., Michael Hiatt, US Radiopharmaceuticals Corp, Paul Crowe, Thomas S McCausland, Michael Nobel, Nuview Diagnostics, LLC, US Radiopharmaceuticals Corp., Mark Hiatt and Thomas S. McCausland |
4:2019cv00442 |
June 14, 2019 |
US District Court for the Eastern District of Texas |
Amos L Mazzant |
Contract: Other |
28 U.S.C. § 1441 |
Plaintiff |
Docket Report
This docket was last retrieved on August 7, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 16 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Maury Dewald, Mark Hiatt, NuView Life Sciences, Inc., NuView Molecular Pharmaceuticals, Inc., Nuview Diagnostics, LLC, US Radiopharmaceuticals Corp..( Deans, Gregory) |
Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for NuView Molecular Pharmaceuticals, Inc. to 9/7/2019; Mark Hiatt to 9/7/2019; NuView Life Sciences, Inc. to 9/7/2019; US Radiopharmaceuticals Corp. to 9/7/2019; Maury Dewald to 9/7/2019; Nuview Diagnostics, LLC to 9/7/2019. 30 Days Granted for Deadline Extension.( rpc, ) |
NOTICE of Deficiency regarding the #15 Defendant's Unopposed First Application for Extension of Time to Answer Complaint submitted by Maury Dewald, Mark Hiatt, NuView Life Sciences, Inc., NuView Molecular Pharmaceuticals, Inc., Nuview Diagnostics, LLC, US Radiopharmaceuticals Corp.. The request exceeds the allowable extension, per Local Rule CV-12. Correction should be made by one business day. (rpc, ) |
Filing 15 ***DEFICIENT. TO BE REFILED. PLEASE DISREGARD*** Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Maury Dewald, Mark Hiatt, NuView Life Sciences, Inc., NuView Molecular Pharmaceuticals, Inc., Nuview Diagnostics, LLC, US Radiopharmaceuticals Corp..( Deans, Gregory) Modified on 8/7/2019 (rpc, ). |
Filing 14 REPORT of Rule 26(f) Planning Meeting by Maury Dewald, Mark Hiatt, NuView Life Sciences, Inc., NuView Molecular Pharmaceuticals, Inc., Nuview Diagnostics, LLC, US Radiopharmaceuticals Corp. JOINT STATUS REPORT (Attachments: #1 Appendix Proposesd Scheduling Order Deadlines)(Deans, Gregory) Modified on 8/7/2019 (rpc, ). |
Filing 13 DEMAND for Trial by Jury by Ian M. Horn. (Sargent, Hunter) |
Filing 12 NOTICE by Maury Dewald, Mark Hiatt, NuView Life Sciences, Inc., NuView Molecular Pharmaceuticals, Inc., Nuview Diagnostics, LLC, US Radiopharmaceuticals Corp. Compliance with Rule 26(a)(1) Initial Disclosures (Deans, Gregory) |
Filing 11 WAIVER OF SERVICE Returned Executed by Thomas S. McCausland. Thomas S. McCausland waiver sent on 7/15/2019, answer due 9/13/2019. (Deans, Gregory) |
Filing 10 WAIVER OF SERVICE Returned Executed by Paul Crowe. (Deans, Gregory) |
Filing 9 SUMMONS Issued as to Michael Nobel. (rpc, ) |
Filing 8 SUMMONS Issued as to Thomas S. McCausland. (rpc, ) |
Filing 7 SUMMONS Issued as to Paul Crowe. (rpc, ) |
Filing 6 AMENDED COMPLAINT against All Defendants, filed by Ian M. Horn. (Attachments: #1 Exhibit A)(Sargent, Hunter) |
Filing 5 ORDER GOVERNING PROCEEDINGS. Rule 26 Meeting Report due by 8/6/2019. Rule 16 Management Conference set for 8/20/2019 at 01:30 PM in Ctrm 208 (Sherman) before District Judge Amos L. Mazzant III. Signed by District Judge Amos L. Mazzant, III on 7/1/2019. (rpc, ) |
Filing 4 ORDER AND ADVISORY. Plaintiff's amended complaint is due thirty (30) days from the date of this order. Defendants' amended answer is due twenty (20) days from receipt of the amended complaint. Any prior deadline for Defendant's answer shall be extended to the date set by this order. Signed by District Judge Amos L. Mazzant, III on 6/19/2019. (rpc, ) |
Filing 3 ***ORIGINALLY FILED IN STATE COURT*** ANSWER to #2 Petition by Mark Hiatt.(rpc, ) |
Filing 2 ***ORIGINALLY FILED IN STATE COURT*** PETITION against All Defendants, filed by Ian M. Horn. (Attachments: #1 Exhibit A)(rpc, ) |
In accordance with the provisions of 28 USC Section 636(c), you are hereby notified that a U.S. Magistrate Judge of this district court is available to conduct any or all proceedings in this case including a jury or non-jury trial and to order the entry of a final judgment. The form #Consent to Proceed Before Magistrate Judge is available on our website. All signed consent forms, excluding pro se parties, should be filed electronically using the event Notice Regarding Consent to Proceed Before Magistrate Judge. (rpc, ) |
Case Assigned to District Judge Amos L. Mazzant, III. (rpc, ) |
Filing 1 NOTICE OF REMOVAL by NuView Molecular Pharmaceuticals, Inc., Michael Hiatt, NuView Life Sciences, Inc., US Radiopharmaceuticals Corp, Maury Dewald, Nuview Diagnostics, LLC from 16th Judicial District Court, Denton County, Texas, case number 19-3772-16. (Filing fee $ 400 receipt number 0540-7311806), filed by NuView Molecular Pharmaceuticals, Inc., Michael Hiatt, NuView Life Sciences, Inc., US Radiopharmaceuticals Corp, Maury Dewald, Nuview Diagnostics, LLC. (Attachments: #1 Exhibit 1 State Court Documents, #2 Exhibit 2 Information Pursuant to Local Rule CV-81(c), #3 Exhibit 3 Civil Cover Sheet)(Deans, Gregory) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Texas Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.